Overexpression of p53 predicts colorectal neoplasia risk in patients with inflammatory bowel disease and mucosa changes indefinite for dysplasia

Risk for Colorectal Neoplasia in Patients with Inflammatory Bowel Disease and Mucosa Indefinite for Dysplasia

(2015) Keith K. Lai et al.   INFLAMMATORY BOWEL DISEASES

Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis

(2013) Preethi G.K. Venkatesh et al.   Journal of Crohns & Colitis

Diagnostic utility of TP53 and cytokeratin 7 immunohistochemistry in idiopathic inflammatory bowel disease-associated neoplasia

(2013) Hao Xie et al.   MODERN PATHOLOGY

Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines

(2012) Timothy L. Zisman et al.   INFLAMMATORY BOWEL DISEASES

Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis

(2011) Fiona D.M. van Schaik et al.   INFLAMMATORY BOWEL DISEASES

Misclassification of dysplasia in patients with inflammatory bowel disease

(2010) Fiona D.M. van Schaik et al.   INFLAMMATORY BOWEL DISEASES

Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis

(2009) Joel R. Pekow et al.   INFLAMMATORY BOWEL DISEASES